SAN DIEGO (AP) — SAN DIEGO (AP) — Tracon Pharmaceuticals Inc. (TCON) on Tuesday reported profit of $439,000 in its fourth quarter.
On a per-share basis, the San Diego-based company said it had profit of 1 cent.
The antibody drug developer posted revenue of $3.4 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TCON at https://www.zacks.com/ap/TCON